DE60107393D1 - Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten - Google Patents

Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten

Info

Publication number
DE60107393D1
DE60107393D1 DE60107393T DE60107393T DE60107393D1 DE 60107393 D1 DE60107393 D1 DE 60107393D1 DE 60107393 T DE60107393 T DE 60107393T DE 60107393 T DE60107393 T DE 60107393T DE 60107393 D1 DE60107393 D1 DE 60107393D1
Authority
DE
Germany
Prior art keywords
tramadol
producing
medicinal product
gastrointestinal diseases
functional gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60107393T
Other languages
English (en)
Other versions
DE60107393T2 (de
Inventor
David Fowler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0004998A external-priority patent/GB0004998D0/en
Priority claimed from GB0021060A external-priority patent/GB0021060D0/en
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of DE60107393D1 publication Critical patent/DE60107393D1/de
Application granted granted Critical
Publication of DE60107393T2 publication Critical patent/DE60107393T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60107393T 2000-03-01 2001-03-01 Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten Expired - Lifetime DE60107393T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0004998 2000-03-01
GB0004998A GB0004998D0 (en) 2000-03-01 2000-03-01 The treatment of functional gastrointestinal disorders
GB0021060A GB0021060D0 (en) 2000-08-25 2000-08-25 Treatment of functional gastrointestinal disorders
GB0021060 2000-08-25
PCT/GB2001/000885 WO2001064202A2 (en) 2000-03-01 2001-03-01 Tramadol for the treatment of functional gastrointestinal disorders

Publications (2)

Publication Number Publication Date
DE60107393D1 true DE60107393D1 (de) 2004-12-30
DE60107393T2 DE60107393T2 (de) 2005-12-01

Family

ID=26243781

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107393T Expired - Lifetime DE60107393T2 (de) 2000-03-01 2001-03-01 Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten

Country Status (6)

Country Link
US (2) US20030119916A1 (de)
EP (1) EP1261324B1 (de)
JP (1) JP5042425B2 (de)
AU (1) AU3582101A (de)
DE (1) DE60107393T2 (de)
WO (1) WO2001064202A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003290406A1 (en) * 2003-12-29 2005-07-21 Council Of Scientific And Industrial Research Herbal composition for gastrointestinal disorders
GB201207907D0 (en) * 2012-05-04 2012-06-20 E Therapeutics Plc Treatment of depression

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
EP0189002B1 (de) 1984-12-20 1993-03-03 Sandoz Ag Behandlung von Gastrointestinalkrankheiten durch Anwendung von 5-HT3-Antagonisten
IL87674A (en) 1987-09-08 1993-08-18 Lilly Co Eli Azabicycloalkyl esters and amides of heterocyclic acids, their preparation and pharmaceutical compositions containing them
DE69226624T3 (de) * 1991-09-06 2009-11-05 Ortho-Mcneil Pharmaceutical, Inc. Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
US5840903A (en) 1992-07-27 1998-11-24 G. D. Searle & Co. 4-aminomethyl-1-azaadamantane derived benzamides
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5738875A (en) 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9523566D0 (en) * 1995-11-17 1996-01-17 Euro Celtique Sa Pharmaceutical formulation
GB2317110B (en) * 1996-09-10 2000-10-18 Ninh Thuy On Anti-diarrhoeal compositions comprising loperamide and an opioid
ATE275394T1 (de) 1997-03-11 2004-09-15 Arakis Ltd R- und s- enantiomere getrennteteile enthaltende dosierungsformen
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
US6376550B1 (en) * 1999-02-09 2002-04-23 Asta Medica Ag Pharmaceutical compositions containing tramadol for migraine
US6194382B1 (en) 1999-03-03 2001-02-27 Albert Einstein College Of Medicine Of Yeshiva University Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists
ES2226886T3 (es) * 1999-08-31 2005-04-01 Grunenthal Gmbh Forma de administracion de accion retardada que contiene sacarinato de tramadol.
EP1313460A2 (de) * 1999-11-09 2003-05-28 Darwin Discovery Limited Therapeutische verwendung und formulierungen von (-)-tramadol

Also Published As

Publication number Publication date
US20030119916A1 (en) 2003-06-26
US8716347B2 (en) 2014-05-06
WO2001064202A2 (en) 2001-09-07
JP2003525241A (ja) 2003-08-26
EP1261324A2 (de) 2002-12-04
US20060217444A1 (en) 2006-09-28
DE60107393T2 (de) 2005-12-01
JP5042425B2 (ja) 2012-10-03
EP1261324B1 (de) 2004-11-24
AU3582101A (en) 2001-09-12
WO2001064202A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE50111250D1 (de) Vorrichtung zur intrakorporalen, minimal-invasiven behandlung eines patienten
DE60015392D1 (de) Verwendung von annexin-modulatoren zur herstellung eines medikaments zur behandlung und/oder vorbeugung von arthritis und arthritischen erkrankungen
DE60029033D1 (de) Verfahren zur Behandlung von Tissuepapier
DE69934813D1 (de) Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen
DE69426320D1 (de) Verwendung von silikon/fluorsilikon kopolymeröl zur herstellung eines arzneimittels zur behandlung von augenerkrankungen
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
ATE214275T1 (de) Verwendung von n-methyl-n-((1s)-1-phenyl-2-((3s)- 3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl- acetamid hydrochlorid zur herstellung von arzneimitteln zur behandlung von entzündlichen darmerkrankungen
ATE300942T1 (de) Verwendung von biguanidederivaten zur herstellung eines vernarbungsfördernden medikaments
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE335487T1 (de) Verwendung von pyridazino 4,5-(b)ö-indole-1- acetamide derivaten zur herstellung eines arzneimittels zur behandlung von durch periphere benzodiazepinrezeptoren-störungen verursachte krankheiten
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
ATE246518T1 (de) Egr-1 zur herstellung eines medikamentes zur behandlung von wunden
DE60113049D1 (de) Verfahren zur Herstellung von natürlichem Käse
DE60128911D1 (de) Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen
DE69635298D1 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
ATE459625T1 (de) Anwendung von cystein-derivaten zur herstellung eines arzneimittels bestimmt zur behandlung von pathologien hervorgehend aus entstehung der protein g het
ATE359285T1 (de) Verwendung von scopinester derivaten zur herstellung von arzneimitteln
DE50107692D1 (de) Verwendung von selenithältigen wässerigen lösungen zur herstellung eines medikaments zur behandlung viraler erkrankungen und pigmentflecken
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60213450D1 (de) Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist
DE60107393D1 (de) Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition